Kenvue Should Have Raised FDA Probe Before IPO, Suit Says
Pharmaceutical company Kenvue Inc. was hit with a proposed class action alleging it failed to inform investors ahead of its initial public offering about a regulatory investigation into the effectiveness of...To view the full article, register now.
Already a subscriber? Click here to view full article